Abstract
Post-chikungunya virus (CHIKV) chronic arthritis shares several immunopathogenic mechanisms with rheumatoid arthritis (RA), which has led to discussions about the probable relationship between the two diseases. Indeed, some studies have suggested a role for CHIKV infection in RA development. However, to the best of our knowledge, the influence of CHIKV on previous RA has not yet been demonstrated. Herein, we analyzed the potential synergism between CHIKV infection and RA on cytokine and chemokine levels. For this, we compared the IL-1β, IL-6, IL-10, IL-17A, CCL2, CXCL8, CXCL9 and CXCL10 levels, in addition to rheumatoid factor (RF) and C-reactive protein (CRP), in patients with post-CHIKV chronic arthritis (named CHIKV group), patients with RA (RA group), and patients with previous RA who were later infected by CHIKV (RA-CHIKV). History of CHIKV infection was confirmed by serology (IgG, ELISA). Cytokines/chemokines were quantified by flow cytometry. RF, CRP, age and sex data were obtained from medical records. IL-1β, IL-6, IL-10 and IL-17A levels were significantly higher in RA-CHIKV compared to the other groups. CXCL8 levels were higher in the CHIKV group than in RA. CXCL9 was higher in CHIKV than in the RA-CHIKV group. CXCL10 was higher in CHIKV than in the other groups. FR levels were higher in RA than in the CHIKV group, and in RA-CHIKV than in CHIKV. No significant difference was observed in CCL2 and CRP, as well as in age and sex. Finally, our findings suggest an interplay between CHIKV infection and RA, which must be analyzed for its possible clinical impact.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs42770-023-00976-6/MediaObjects/42770_2023_976_Fig1_HTML.png)
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article.
References
Silva JVJ Jr, Ludwig-Begall LF, Oliveira-Filho EF, Oliveira RAS, Durães-Carvalho R, Lopes TRR, Silva DEA, Gil LHVG (2018) A sco** review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control. Acta Trop 188:213–224. https://doi.org/10.1016/j.actatropica.2018.09.003
ICTV (2021) Virus Taxonomy, 2021. ICTV International Committee on Taxonomy of Viruses. https://ictv.global/taxonomy. Accessed 19 Nov 2022
Staples JE, Susan LH, Ann MP (2020) Chapter 4: Travel-related Infectious Diseases. https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/chikungunya. Accessed 19 Nov 2022
Mahendradas P, Avadhani K, Shetty R (2013) Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect 3:35. https://doi.org/10.1186/1869-5760-3-35
Mehta R, Gerardin P, de Brito CAA, Soares CN, Ferreira MLB, Solomon T (2018) The neurological complications of chikungunya virus: A systematic review. Rev Med Virol 28:1978. https://doi.org/10.1002/rmv.1978
Crosby L, Perreau C, Madeux B, Cossic J, Armand C, Herrmann-Storke C, Najioullah F, Valentino R, Thiéry G (2016) Severe manifestations of chikungunya virus in critically ill patients during the 2013–2014 Caribbean outbreak. Int J Infect Dis 48:78–80. https://doi.org/10.1016/j.ijid.2016.05.010
Calabrese LH (2008) Emerging viral infections and arthritis: the role of the rheumatologist. Nat Clin Pract Rheumatol 4:2–3. https://doi.org/10.1038/ncprheum0679
Hoarau JJ, Jaffar BMC, Krejbich TP, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzère BA, Bruniquet S, Jaffar BZ, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debré P, Autran B, Gasque P (2010) Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184:5914–5927. https://doi.org/10.4049/jimmunol.0900255
Rodríguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzón FS, Hurtado-Zapata SJ (2016) Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) 68:1849–1858. https://doi.org/10.1002/acr.22900
Goupil BA, Mores CN (2016) A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis. Open Rheumatol J 30:129–140. https://doi.org/10.2174/1874312901610010129
Amaral JK, Bilsborrow JB, Schoen RT (2020) Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common. Am J Med 133:91–97. https://doi.org/10.1016/j.amjmed.2019.10.005
Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis 90:772–9. J Clin Invest. https://doi.org/10.1172/JCI115950
Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S (1993) Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 69:83–91. https://doi.org/10.1006/clin.1993.1153
Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Barkham T, Yang H, Rénia L, Leo YS, Ng LF (2011) Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–57. https://doi.org/10.1093/infdis/jiq042
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219. https://doi.org/10.1056/NEJMra1004965
Ninla-Aesong P, Mitarnun W, Noipha K (2019) Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand. Viral Immunol 32:442–452. https://doi.org/10.1089/vim.2019.0064
Ferreira AS, Baldoni NR, Cardoso CS, Oliveira CDL (2021) Biomarkers of severity and chronification in chikungunya fever: a systematic review and meta-analysis. Rev Inst Med Trop Sao Paulo 63:16. https://doi.org/10.1590/S1678-9946202163016
Nakaya HI, Gardner J, Poo YS, Major L, Pulendran B, Suhrbier A (2012) Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum 64(11):3553–3563. https://doi.org/10.1002/art.34631
Fourie ED, Morrison JG (1979) Rheumatoid arthritic syndrome after chikungunya fever. S Afr Med J 56(4):130–132
Bouquillard E, Combe B (2009) Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis 68:1505–1506. https://doi.org/10.1136/ard.2008.097626
Burt F, Chen W, Mahalingam S (2014) Chikungunya virus and arthritic disease. Lancet Infect Dis 9:789–790. https://doi.org/10.1016/S1473-3099(14)70869-2
Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517–1527. https://doi.org/10.1084/jem.179.5.1517
Lee EY, Lee ZH, Song YW (2012) The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev 12:554–557. https://doi.org/10.1016/j.autrev.2012.10.001
Domenicantonio DA (2014) Rheumatoid arthritis and the alpha-chemokine IP-10. Clin Ter 165:447–451. https://doi.org/10.7417/CT.2014.1791
Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B (2014) Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World J Orthop 5:516–536. https://doi.org/10.5312/wjo.v5.i4.516
Hernández-Bello J, Oregón-Romero E, Vázquez-Villamar M, García-Arellano S, Valle Y, Padilla-Gutiérrez JR, Román-Fernández IV, Palafox-Sánchez CA, Martínez-Bonilla GE, Muñoz-Valle JF (2017) Aberrant expression of interleukin-10 in rheumatoid arthritis: Relationship with IL10 haplotypes and autoantibodies. Cytokine 95:88–96. https://doi.org/10.1016/j.cyto.2017.02.022
Lee JH, Kim B, ** WJ, Kim HH, Ha H, Lee ZH (2017) Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis. Arthritis Res Ther 19:163. https://doi.org/10.1186/s13075-017-1353-6
Pandya JM, Lundell AC, Andersson K, Nordström I, Theander E, Rudin A (2017) Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker. Arthritis Res Ther 19:20. https://doi.org/10.1186/s13075-017-1224-1
Paparo SR (2019) Rheumatoid arthritis and the Th1 chemokine MIG. Clin Ter 170:472–477. https://doi.org/10.7417/CT.2019.2178
Lin T, Geng T, Harrison AG, Yang D, Vella AT, Fikrig E, Wang P (2020) CXCL10 Signaling Contributes to the Pathogenesis of Arthritogenic Alphaviruses. Viruse 12:1252. https://doi.org/10.3390/v12111252
Jacob-Nascimento LC, Carvalho CX, Silva MMO, Kikuti M, Anjos RO, Fradico JRB, Campi-Azevedo AC, Tauro LB, Campos GS, Moreira PSDS, Portilho MM, Martins-Filho OA, Ribeiro GS, Reis MG (2021) Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection. Front Immunol 12:744183. https://doi.org/10.3389/fimmu.2021.744183
NRAS (2022) What is Rheumatoid arthritis (RA). NRAS National Rheumatoid Arthritis Society. https://nras.org.uk/resource/what-is-ra/. Accessed 19 Nov 2022
IBGE (2010) Synopsis of the 2010 Population Census (Pernambuco). IBGE Brazilian Institute of Geography and Statistics. https://censo2010.ibge.gov.br/sinopse/index.php?dados=210&uf=26. Accessed 19 Nov 2022
Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M (2021) IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 7:06155. https://doi.org/10.1016/j.heliyon.2021.e06155
Lu L, Zhang H, Dauphars DJ, He YW (2020) A Potential Role of Interleukin 10 in COVID-19 Pathogenesis. Trends Immunol 42:3–5. https://doi.org/10.1016/j.it.2020.10.012
Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S (2012) High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009–2010 outbreak in Thailand. Microbiol Immunol 56:134–138. https://doi.org/10.1111/j.1348-0421.2011.00417.x
Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7:2137. https://doi.org/10.1371/journal.pntd.0002137
Pope JE, Choy EH (2021) C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum 51:219–229. https://doi.org/10.1016/j.semarthrit.2020.11.005
Ingegnoli F, Castelli R, Gualtierotti R (2003) Rheumatoid factors: clinical applications. Dis Markers 35:727–734. https://doi.org/10.1155/2013/726598
Acknowledgements
The authors thank the patients who agreed to participate and collaborate with the study.
Funding
LAB thanks the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (Brazil) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (Brazil) for her scholarship. YCSB thanks the CNPq (Brazil) for her scholarship. JVJSJr was supported by Financiadora de Estudos e Projetos (FINEP) DTI-A-1. MRCDC was supported by CNPq research fellowship.
Author information
Authors and Affiliations
Contributions
Conceptualization: LAB, YCSB, JPG, JVJSJr, ALBPD, CDLM and MRCDC; Data collection: LAB and YCSB; Experiments: LAB, YCSB, JPG and VMBL; Data analyses: LAB, YCSB, JPG, JVJSJr, VMBL, ALBPD, CDLM and MRCDC; Manuscript preparation: LAB, YCSB, JPG, JVJSJr and MRCDC; Supervision: MRCDC. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval statement and Patient consent statement
The study was approved by the Research Ethics Committee of the Health Sciences Center at UFPE (protocol 17712619.5.0000.5208).
Consent for publication
All authors agreed the work to be published
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: Mauricio Nogueira
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bezerra, L.A., da Silva Bastos, Y.C., Gonçales, J.P. et al. Synergism between chikungunya virus infection and rheumatoid arthritis on cytokine levels: Clinical implications?. Braz J Microbiol 54, 885–890 (2023). https://doi.org/10.1007/s42770-023-00976-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-023-00976-6